Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Effectiveness of ustekinumab and improvement in real-world work productivity and associated indirect costs in patients with moderate-severe Crohn's disease in the United States of America.
Journal: Current medical research and opinion
Published: January 19, 2026
Serum protein profiles differ with adalimumab and ustekinumab treatment in moderately to severely active Crohn's disease.
Journal: Journal of Crohn's & colitis
Published: November 19, 2025
Burden of chronic corticosteroid use among patients with ulcerative colitis initiated on targeted treatment or conventional therapy in the United States.
Journal: Journal of managed care & specialty pharmacy
Published: February 03, 2024
Long-term persistence and other treatment patterns among bio-naïve patients with Crohn's disease treated with ustekinumab or adalimumab.
Journal: Current medical research and opinion
Published: August 11, 2023
Economic and clinical burden of chronic corticosteroid use in patients with Crohn[apos]s disease initiated on biologic or conventional therapies in the US: A retrospective claims study.
Journal: Journal of the American Pharmacists Association : JAPhA
Published: August 09, 2023
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 30, 2023
Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn's Disease or Ulcerative Colitis in the United States.
Journal: Crohn's & colitis 360
Published: March 11, 2022
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Journal: The American journal of gastroenterology
Published: January 06, 2022
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Journal: Lancet (London, England)
Published: November 03, 2021
Trends in US emergency department visits and subsequent hospital admission among patients with inflammatory bowel disease presenting with abdominal pain: a real-world study from a national emergency department sample database.
Journal: Journal of market access & health policy
Published: May 10, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026